Related Experiment Video
Updated: Sep 10, 2025

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Incremental Cost and Length of Stay Associated With Complications of Transcatheter Aortic Valve Replacement
Steven D Culler1, Matthew R Reynolds2, Aaron D Kugelmass3
1Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Insights
Transcatheter aortic valve replacement (TAVR) complications significantly increase hospital costs by over $12,000 per patient. Mitigating these adverse events in TAVR procedures offers substantial cost savings.
Area of Science:
- Cardiovascular Medicine
- Health Economics
- Medical Device Technology
Background:
- Transcatheter aortic valve replacement (TAVR) is the leading procedure for aortic valve replacement, with nearly 100,000 annual US procedures.
- The economic impact of TAVR complications on hospital resource utilization remains incompletely understood.
Purpose of the Study:
- To quantify the additional hospital resource use and associated costs linked to TAVR complications.
- To analyze the financial burden imposed by adverse events following TAVR procedures.
Main Methods:
- Utilized the 2020 Medicare Provider Analysis and Review file for 66,893 TAVR beneficiaries.
- Employed ICD-10-CM codes to identify complications and cost-to-charge ratios for hospital cost calculation.
- Applied multivariable regression to estimate incremental costs and length of stay (LOS) associated with complications.
Main Results:
- In 2020, 31.1% of Medicare TAVR patients experienced complications, increasing mean hospitalization costs by $15,377 and LOS by 2.8 days.
- Risk-adjusted incremental cost of complications was $12,953, with surgical aortic valve replacement, dialysis-requiring renal failure, and in-hospital mortality being the most costly.
- Complications contributed $320 million in additional costs, representing 8.7% of total Medicare TAVR hospital expenditures.
Conclusions:
- Approximately one in three Medicare TAVR patients encounter serious complications, significantly elevating hospital resource use.
- Despite TAVR advancements, substantial cost savings are achievable through focused efforts on complication reduction and mitigation strategies.
Background:
Transcatheter aortic valve replacement (TAVR) has become the leading form of aortic valve replacement, with nearly 100,000 annual procedures in the United States. However, the impact of complications on hospital costs is not well understood.
Objectives:
The purpose of this study was to quantify the additional hospital resource use and costs associated with TAVR complications.
Methods:
Medicare Provider Analysis and Review file from fiscal year 2020 identified 66,893 beneficiaries undergoing TAVR. International Classification of Diseases-10th-Clinical Modification diagnostic and procedure codes were used to identify complications and hospital costs were calculated using cost-to-charge ratios. Multivariable regression estimated the incremental cost and length of stay (LOS) associated with complications.
Results:
In 2020, 31.1% of the 66,893 Medicare beneficiaries who underwent a TAVR experienced one or more complications. The mean cost of a TAVR hospitalization was $54,988 ± $26,744 and the mean LOS was 3.1 ± 4.5 days. Patients who experience any of the complications increased costs by $15,377 and incremental LOS by 2.8 days compared to those not experiencing complications. After adjustments for patient risk factors, the incremental cost of complications was $12,953. Surgical aortic valve replacement ($42,924), acute renal failure requiring dialysis ($34,606), and in-hospital mortality ($25,307) had the highest risk-adjusted costs. Complications accounted for $320 million in additional costs, representing 8.7% of the total hospital cost for Medicare TAVR patients.
Conclusions:
In contemporary practice, approximately one in 3 Medicare TAVR patients experience serious complications, substantially increasing hospital resource use. Despite improvements in TAVR outcomes and efficiency, additional cost savings can be achieved through complication mitigation.
More Related Videos
Related Concept Videos
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm III: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Aortic Regurgitation III: Medical Management
Mitral Stenosis IV: Nursing Management

